← Back to Search

Behavioural Intervention

Best practice alert for the notification of patient HFrEF and recommended evidence-based medical therapies (NO drugs are being administered in this trial) for Heart Failure (PROMPT-HF Trial)

N/A

Waitlist Available

Led By Tariq Ahmad, MD, MPH

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed from the date of randomization to discharge date, assessed up to 12 months.

Awards & highlights

PROMPT-HF Trial Summary

This trial tests whether a best practice alert recommending evidence-based medical therapies can improve care for heart failure patients with reduced ejection fraction, compared to usual care.

PROMPT-HF Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed from the date of randomization to discharge date, assessed up to 12 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed from the date of randomization to discharge date, assessed up to 12 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed from the date of randomization to discharge date, assessed up to 12 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of patients with HFrEF with an increase in prescribed evidence-based HFrEF medical therapy

Secondary outcome measures

30-day emergency department visits

30-day hospital readmission rates

6 months all-cause mortality

+5 more

PROMPT-HF Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Electron Health Record-based Provider AlertExperimental Treatment1 Intervention

Providers will receive a best practice alert for each of their eligible patients upon opening of the order entry screen in the patient's medical record. The alert will inform the provider to the presence of HFrEF and of the patient's current left ventricular ejection fraction, most recent blood pressure and heart rate, most recent potassium and estimated glomerular filtration rate, and current evidence-based medications for HFrEF. It will also provide access to an order set with recommended evidence-based HFrEF therapies as well as a link to the best available guideline-recommended information regarding the treatment of heart failure.

Group II: Usual CareActive Control1 Intervention

Providers will not receive an alert and will proceed with usual care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

AstraZenecaIndustry Sponsor

4,259 Previous Clinical Trials

288,592,890 Total Patients Enrolled

84 Trials studying Heart Failure

165,014 Patients Enrolled for Heart Failure

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,736,656 Total Patients Enrolled

32 Trials studying Heart Failure

54,987 Patients Enrolled for Heart Failure

Tariq Ahmad, MD, MPHPrincipal InvestigatorYale University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still an open enrollment period for this clinical trial?

"Affirmative. According to clinicaltrials.gov, this medical trial is currently recruiting patients; it was first published on July 7th 2021 and has since been updated multiple times with the last update occuring on September 29th 2022. The study requires 1012 participants from a single site."

Answered by AI

What is the highest number of participants enrolled in this experiment?

"Affirmative. According to clinicaltrials.gov, this clinical trial is currently enrolling participants and was published on July 7th 2021 with the most recent update occurring September 29th 2022. 1012 individuals must be recruited from a single centre for the experiment's success."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting

2021. "PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04686604.